Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


EpiSonic Multi-Functional Bioprocessor 1100

Product Image
Product Description

The EpiSonic™ Multi-Functional Bioprocessor 1100 system, an upgrade from the previous EpiSonic™ 1000 model, is a high-throughput capable sonication instrument of the latest generation for use in a wide range of biological applications, in particular for DNA and chromatin shearing. This completely digital instrument allows for simultaneous processing of 96 samples or more and can be easily integrated into existing lab workflows.

Applications

The EpiSonic™ 1100 was designed and built with the processing of biological samples specifically in mind.

•    DNA Shearing
•    Chromatin Shearing
•    Cell Disruption/Lysis

Features

The EpiSonic™ 1100 is a highly advanced ultrasonic instrument that incorporates Digitally Adaptive Sonocavitation™ (DAS) technology for efficiently processing biological samples with the following key features:

•    Touch Screen Control - Simple, modern operation with intuitive menu navigation
•    High Degree of Precision - Adjust amplitude levels 1% at a time, between 1% and 100%
•    Programmable Memory - Store successful protocols for future use
•    Isothermal Environment - Included cooling system automatically recirculates chilled water to maintain sample integrity and prevent thermal degradation
•    True High Throughput - Simultaneously process from 1 to 96 or more samples with standard 0.2ml PCR single tubes or 96-well PCR plates
•    Shallow Waterbath - Less liquid medium allows for faster and highly focused sonication on samples
•    Closed Vessel Processing - Non-contact sonication in sealed tubes or wells prevents contamination and sample loss
•    Scalability - Simple, removable, and interchangable vessel rack allows for expansion to different vessel sizes
•    Fast Processing - Shear 96 DNA samples to 100-500 bp (average 300 bp) fragments in just 10-20 minutes
•    Real-Time Energy Monitoring - Live screen output of amplitude, wattage, and joule readings
•    Real-Time Temperature Monitoring - Live screen output of temperature in sample reservoir (temperature probe required)
•    Improved Bio-Safety - No aerosol formation and little foaming; no tedious manipulation of probes
•    Workflow Integration - Streamlines into high-throughput or multi-sample chromatin immunoprecipitation (ChIP) and massively parallel sequencing workflows
•    Automatic Overload Prevention - Detects faults and shuts down to prevent damage to circuits
•    No Moving Parts - Eliminates any possibility of mechanical failure or breakdown
•    Extensive Warranty - Backed by a 20 month warranty to ensure quality and customer satisfaction

Product EpiSonic Multi-Functional Bioprocessor 1100
Company Epigentek Group
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Epigentek Group
Epigentek Group Inc. 110 Bi County Blvd. Ste 122 Farmingdale, NY 11735

Tel: International: 1 718 484-3990
Fax: 1 718 484-3956
Email: info@epigentek.com



Scientific News
MicroRNA Pathway Could Lead to New Avenues for Leukemia Treatment
Cancer researchers at the University of Cincinnati have found a particular signaling route in microRNA (miR-22) that could lead to targets for acute myeloid leukemia, the most common type of fast-growing cancer of the blood and bone marrow.
Analysis of Dog Genome will Provide Insight into Human Disease
An important model in studying human disease, the non-coding RNA of the canine genome is an essential starting point for evolutionary and biomedical studies – according to a new study led by The Genome Analysis Centre (TGAC).
New Blood Test for The Earlier Diagnosis of Breast Cancer Spread
Researchers at University of Westminster have confirmed that a new blood test can detect if breast cancer has spread to other parts of the body.
First Gene Therapy Successful Against Human Aging
American woman gets biologically younger after gene therapies.
Targeting an ‘Undruggable’ Cancer Gene
RAS genes are mutated in more than 30 percent of human cancers and represent one of the most sought-after cancer targets for drug developers.
Altered Metabolism of Four Compounds Drives Glioblastoma Growth
Findings suggest new ways to treat the malignancy, slow its progression and reveal its extent more precisely.
Improving Engineered T-Cell Cancer Treatment
Purdue University researchers may have figured out a way to call off a cancer cell assassin that sometimes goes rogue and assign it a larger tumor-specific "hit list."
Uncovering How Some Breast Cancers Resist Treatment
A targeted therapy for triple-negative breast cancer (TNBC), the most aggressive form of breast cancer, has shown potential promise in a recently published study.
Characterizing Cancerous Genomic Variations
Tested on large tumor genomics database, REVEALER method allows researchers to connect genomics to cell function.
Activating Cancer-Killing Immune Cells
A UCL research team have discovered that cutting off a sleep-switch on immune cells inside a tumour wakes up the cells and enables the immune system to hunt down and destroy cancer.

SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!